Inovio Pharmaceuticals (INO) Receives a Buy from H.C. Wainwright


H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Inovio Pharmaceuticals (INO) today and set a price target of $13. The company’s shares closed yesterday at $4.73.

Selvaraju said:

“Our 12-month price target is derived from a market value of the firm at $1.4B, including a discounted cash flow-based asset value for 15% discount rate, 2% terminal growth rate and 80% probability of approval.”

According to TipRanks.com, Selvaraju ‘s ranking currently consits of no stars on a 0-5 ranking scale, with an average return of -15.2% and a 25.3% success rate. Selvaraju covers the Healthcare sector, focusing on stocks such as Biospecifics Technologies Corp, EyePoint Pharmaceuticals Inc, and Bausch Health Companies Inc.

Currently, the analyst consensus on Inovio Pharmaceuticals is a Moderate Buy with an average price target of $10.50, which is a 122.0% upside from current levels. In a report released yesterday, Maxim Group also maintained a Buy rating on the stock with a $8 price target.

See today’s analyst top recommended stocks >>

Based on Inovio Pharmaceuticals’ latest earnings release for the quarter ending September 30, the company reported a quarterly GAAP net loss of $25.02 million. In comparison, last year the company had a GAAP net loss of $21.51 million.

Based on the recent corporate insider activity of 25 insiders, corporate insider sentiment is neutral on the stock. Most recently, in December 2018, Avtar Dhillon, a Director at INO bought 25,000 shares for a total of $50,000.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Inovio Pharmaceuticals, Inc. engages in the development of active DNA immunotherapies for cancer and infectious diseases. Its portfolio of immune therapies includes SynCon immunotherapies and electroporation delivery systems. The company was founded on June 29, 1983 and is headquartered in Plymouth Meeting, PA.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts